Advertisement
Coordinated by the Ohio EPA, the award seeks to acknowledge Ohiobusinesses and organizations demonstrating a commitment to go above and beyondcompliance, maintain aggressive environmental performance goals, and provide aprocess for communicating with others about program activities and progresstoward established goals. Submitted nominations were rated and the Ohio EPAcompleted site audits with the finalists to select the eight chosen honorees."I'm honored to recognize these forward-thinking award winners, which have alldemonstrated cutting-edge achievements and a commitment to environmentalstewardship in Ohio," said Ohio EPA Director Chris Korleski in a press releaseissued by the Governor's office. Governor Ted Strickland added, "Thesecompanies are leaders in protecting Ohio's natural resources whileimplementing innovative approaches that reduced the cost of doing business,improved company efficiency, and enhanced the quality of life and theenvironment in their communities. I commend their efforts," More informationabout the award is available at:http://www.epa.state.oh.us/ocapp/stewardship.html.
Advertisement
Ben Venue Laboratories, Inc. Cares
Caring for the environment is one of the many ways Ben Venue works to makea difference. Each day, employees work to fulfill the company mission toprovide their customers with pharmaceutical products that improve people'shealth and quality of life. This commitment to others also stems deeply intohow the organization gives back to the community through many avenuesincluding responsible environmental stewardship. With support from all levelsof the organization, the environmental health and safety management systemcontinues to take on new life with each passing year. From activitiesincluding the careful consideration for environmentally-friendly constructiondesign to numerous grass-roots employee efforts, Ben Venue cares about thefootprint it maintains and the impact on the environment. Employees started aWaste Minimization and Recycling Team in 2005 to identify routes to recyclewaste streams. Successes include saving valuable landfill space andsignificantly reducing waste disposal costs. The company recycled and reused35 tons of material in 2005, 360 tons in 2006 and over 730 tons in 2007. Aprecious-metal recycling program that began in 2007 recovered over 170 troyounces of platinum for a return of more than $265,000. A water reclamationsystem installed in 2006 saved more than 7 million gallons of water in 2006with a cost savings of $57,000. The most recent accomplishment was thecompletion of the LEED Silver Certification application for its newestfacility, a 90,000 square foot Lab and Office building. President and COO,Thomas Murphy stated, "This commitment is at the heart of how we conductbusiness today and is sure to bring about even greater results for thefuture."
About Ben Venue Laboratories, Inc.
Ben Venue Laboratories, Inc. was founded in 1938 and is a leading contractmanufacturer of highly complex, sterile injectable drug products for theglobal pharmaceutical industry. It also markets its own line of genericsterile injectables to hospitals and alternate care markets in North Americathrough its Bedford Laboratories division -- currently offering a variety ofproducts including oncology, cardiovascular, anesthesia, antipsychotic andvarious other products. BVL has been under contract with the National CancerInstitute since 1967 to develop parenteral dosage forms for many anticanceragents. It has also manufactured various AIDS-specific drugs in conjunctionwith the NCI. Ben Venue is located in Bedford, Ohio and employs more than1,100 people. For more information on Ben Venue Laboratories, visitwww.benvenue.com.
Ben Venue is a U.S. subsidiary of Boehringer Ingelheim Corporation(Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.
About Boehringer Ingelheim
Boehringer Ingelheim Corporation based in Ridgefield, CT, is the USheadquarters to seven subsidiaries and a member of the Boehringer Ingelheimgroup of companies.
The Boehringer Ingelheim group is one of the world's 20 leadingpharmaceutical companies. Headquartered in Ingelheim, Germany, it operatesglobally with 135 affiliates in 47 countries and approximately 39,800employees. Since it was founded in 1885, the family-owned company has beencommitted to researching, developing, manufacturing and marketing novelproducts of high therapeutic value for human and veterinary medicine.
In 2007, Boehringer Ingelheim posted net sales of US $15.0 billion (10.9billion euro) while spending approximately one-fifth of net sales in itslargest business segment, Prescription Medicines, on research and development.
For more information on Boehringer Ingelheim, please visithttp://us.boehringer-ingelheim.com.
SOURCE Ben Venue Laboratories, Inc.
